Cargando…

SUN-LB65 Circulating Micrornas Linked to Bone Metabolism Are Affected by Sequential Anti Osteoporotic Treatment in Postmenopausal Osteoporosis

Depending on osteoporosis severity a long-term treatment, often in the form of a sequential regimen, may be required. The expression of microRNAs (miRs) related to bone metabolism in the serum is potentially affected by anti-osteoporotic treatment. Here, we investigated the effect of sequential trea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yavropoulou, Maria, Makras, Polyzois, Anastasilakis, Athanasios, Papatheodorou, Athanasios, Rauner, Martina, Hofbauer, Lorenz C, Tsourdi, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Bone and Mineral Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207965/ http://dx.doi.org/10.1210/jendso/bvaa046.2001

Ejemplares similares

Circulating noggin levels following treatment with denosumab or teriparatide in postmenopausal women with low bone mass
por: Anastasilakis, Athanasios D., et al.
Publicado: (2019)

OR13-05 Romosozumab Treatment Lowers the Incidence of New Vertebral Fractures Across All Fracture Severity Grades Among Postmenopausal Women with Osteoporosis
por: Feldman, Robert, et al.
Publicado: (2020)

MON-LB71 Adult Hypophosphatasia and Postmenopausal Osteoporosis: A Challenging Case
por: Abramof-Ness, Rosane, et al.
Publicado: (2020)

SAT-LB65 A Rare Existence
por: Bedia, Jiselle Aimee Yaplito, et al.
Publicado: (2020)

SUN-LB67 Revisit Serum Calcium Correction
por: Li, Yulong, et al.
Publicado: (2020)

MON-LB65 Lithium: The Culprit of Multiple Endocrinopathies
por: Yau, Alice, et al.
Publicado: (2020)

SUN-386 Treatment Outcomes of Intravenous Zoledronic Acid vs Oral Alendronate in Postmenopausal Women with Osteoporosis
por: Pyone, Zar Chi, et al.
Publicado: (2020)

SUN-389 Trends in Osteoporosis Treatment Uptake and Persistence Among Postmenopausal Women in the U.S., 2010–2015
por: Kim, Min, et al.
Publicado: (2020)

SUN-LB64 Urine Phosphoethanolamine Is an Underutilized Biomarker for Hypophosphastasia
por: Shajani-Yi, Zahra, et al.
Publicado: (2020)

SUN-LB66 Oral Risedronate Treatment in Children With Osteogenesis Imperfecta
por: Nguyen, Antoine T, et al.
Publicado: (2020)

Lipid Profile after Pharmacologic Discontinuation and Restoration of Menstruation in Women with Endometriosis: A 12-Month Observational Prospective Study
por: Anastasilakis, Athanasios D., et al.
Publicado: (2023)

SAT-LB090 Osteoporosis in Menopausal Women with Autoimmune Thyroiditis
por: Preda, Cristina, et al.
Publicado: (2019)

SUN-LB089 Mild Form of Childhood Hypophosphatasia: A Novel Mutation
por: Benzrihen, María, et al.
Publicado: (2019)

SUN-LB088 Octreotide Induced Hypocalcemia in Case of Familial Hypocalciuric Hypercalcemia
por: Alkhazaali, Ali, et al.
Publicado: (2019)

SUN-LB090 Accounting for Skeletal Maturation in the Assessment of Pediatric Bone Mineral Density
por: McCormack, Shana, et al.
Publicado: (2019)

SUN-LB73 Is It Possible to Optimize Resources in Bone-Alkaline Phosphatase Medical Request?
por: Sequera, Ana M, et al.
Publicado: (2020)

SUN-LB091 Impact of Albumin Corrected Calcium on the Prevalence and Categories of Hypercalcemia in Hospitalized Patients
por: Balasubramanian, Priyadarshini, et al.
Publicado: (2019)

SUN-LB72 The Relationship Between Estrogen Exposure and Bone Health in Women With Cystic Fibrosis
por: Arora, Neha, et al.
Publicado: (2020)

SUN-377 Efficacy of Low Dose Denosumab in Maintaining Bone Mineral Density in Postmenopausal Women with Osteoporosis: A Real World, Prospective Observational Study
por: Khan, Aliya Aziz, et al.
Publicado: (2020)

SUN-LB63 Optic Disc Edema in Patients With Craniofacial Fibrous Dysplasia / McCune-Albright
por: Raborn, Layne, et al.
Publicado: (2020)

Approach to the management of β thalassemia major associated osteoporosis - a long-standing relationship revisited
por: Yavropoulou, Maria P., et al.
Publicado: (2022)

SUN-391 Denosumab Treatment of Patients with Osteoporosis and Idiopathic Hypercalciuria
por: Chu, Winston S, et al.
Publicado: (2020)

SUN-LB092 The Role of the Modified Performance-Oriented Mobility Assessment Tool in the Evaluation of Gait in Adults with Hypophosphatasia
por: Dahir, Kathryn, et al.
Publicado: (2019)

SUN-LB74 Radiofrequency Echographic Multi-Spectrometry (REMS) for the Assessment of Bone Strength and Fracture Risk Prediction
por: Ciardo, Delia, et al.
Publicado: (2020)

Gender Predilection in Sporadic Parathyroid Adenomas
por: Yavropoulou, Maria P., et al.
Publicado: (2020)

Irisin and Bone in Sickness and in Health: A Narrative Review of the Literature
por: Tsourdi, Elena, et al.
Publicado: (2022)

Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab
por: Anastasilakis, Athanasios D, et al.
Publicado: (2012)

SUN-LB093 Change in Bone Mineral Density over One Year Was Not Associated with FGF-23 in Patients New to Dialysis
por: Roy, Neil, et al.
Publicado: (2019)

SUN-LB085 Complicated Hungry Bone Syndrome Due to Tertiary Hyperparathyroidism in a Patient with Kidney Transplant: A Case to Remember
por: Jimenez-Zuluaga, Jose, et al.
Publicado: (2019)

SUN-LB68 Advanced Glycation Endproducts Are Associated With Worse Bone Material Strength in Older Adults With and Without Type 2 Diabetes
por: Samakkarnthai, Parinya, et al.
Publicado: (2020)

SUN-LB69 A Comparison Between Weight Loss Associated Bone Loss From Lifestyle Measures Versus Bariatric Surgery
por: La, Betty, et al.
Publicado: (2020)

SUN-LB087 Successful Prevention of Common Complications of Severe Hypercalcemia Secondary to Subcutaneous Fat Necrosis of the Newborn Following Whole Body Therapeutic Hypothermia
por: Ilaka-Chibuluzo, Sandra, et al.
Publicado: (2019)

SUN-LB70 Bone Mineral Density, Vitamin D Status and Bone Turnover Markers in Thai Youth With Graves’ Disease: A Pilot Study
por: Wiromrat, Pattara, et al.
Publicado: (2020)

SUN-374 Decisions to Accept or Decline Pharmacologic Osteoporosis Therapy After Attending a Novel Patient-Centred Educonsult Program for Osteoporosis (PEP-OP)
por: Liu, Crystal Sixian, et al.
Publicado: (2020)

SAT-LB68 A Rare De Novo Mutation in LRP5 Gene in an Adolescent Female With Juvenile Onset Primary Osteoporosis
por: Shum, Betty J, et al.
Publicado: (2020)

SUN-395 Pelvic Bone Density Is Lower Than Bone Density of Hip and Femoral Neck in Postmenopausal Women
por: Mohseni, Mahshid, et al.
Publicado: (2020)

SUN-512 Denosumab Improves Trabecular but Not Cortical Bone Osteoporosis in a Patient with Refractory Primary Hyperparathyroidism
por: Alhassan, Sharifa, et al.
Publicado: (2019)

SAT-LB72 Design of the PaTH Forward Phase 2 Trial of TransCon PTH, a Long-Acting PTH, in Patients With Hypoparathyroidism
por: Khan, Aliya Aziz, et al.
Publicado: (2020)

Rebound-associated vertebral fractures may occur in sequential time points following denosumab discontinuation: need for prompt treatment re-initiation
por: Anastasilakis, Athanasios D., et al.
Publicado: (2020)

OR03-1 The Effect of Abaloparatide on Bone Mineral Density and Fracture Incidence in Postmenopausal Women with Osteoporosis and Osteoarthritis
por: Lane, Nancy, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ik0lug4ghup182tgsg4fde5f5h